These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 20472470

  • 1. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding.
    Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, Sturm J, Scott R, Whyte S, Attia J.
    J Stroke Cerebrovasc Dis; 2011; 20(2):134-44. PubMed ID: 20472470
    [Abstract] [Full Text] [Related]

  • 2. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level.
    Ovbiagele B, Saver JL.
    Cerebrovasc Dis; 2010; 29(1):50-6. PubMed ID: 19893312
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.
    Chakraborty B, Chowdhury D, Vishnoi G, Goswami B, Kishore J, Agarwal S.
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655
    [Abstract] [Full Text] [Related]

  • 4. Association of genetic variants of fibrinolytic system with stroke and stroke subtypes.
    Babu MS, Prabha TS, Kaul S, Al-Hazzani A, Shafi G, Roy S, Balakrishna N, Jyothy A, Munshi A.
    Gene; 2012 Mar 01; 495(1):76-80. PubMed ID: 22240314
    [Abstract] [Full Text] [Related]

  • 5. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome.
    Machumpurath B, Davis SM, Yan B.
    Cerebrovasc Dis; 2011 Mar 01; 31(3):278-83. PubMed ID: 21178353
    [Abstract] [Full Text] [Related]

  • 6. Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.
    Hallevi H, Albright KC, Martin-Schild SB, Barreto AD, Morales MM, Bornstein N, Ifejika NL, Shuaib A, Grotta JC, Savitz SI, VISTA investigators.
    Cerebrovasc Dis; 2009 Mar 01; 28(4):341-8. PubMed ID: 19628935
    [Abstract] [Full Text] [Related]

  • 7. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ.
    Cerebrovasc Dis; 2010 Feb 01; 29(3):263-7. PubMed ID: 20090317
    [Abstract] [Full Text] [Related]

  • 8. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
    Adamski MG, Turaj W, Slowik A, Wloch-Kopec D, Wolkow P, Szczudlik A.
    Acta Neurol Scand; 2009 Aug 01; 120(2):94-100. PubMed ID: 19154538
    [Abstract] [Full Text] [Related]

  • 9. Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese.
    Chen CH, Lo YK, Ke D, Liu CK, Liou CW, Wu HL, Lai ML, Southern Taiwan Young Stroke Study Group.
    J Neurol Sci; 2004 Dec 15; 227(1):1-5. PubMed ID: 15546585
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetic variants in the promoter region of the ALOX5AP gene and susceptibility of ischemic stroke.
    Ji R, Jia J, Ma X, Wu J, Zhang Y, Xu L.
    Cerebrovasc Dis; 2011 Dec 15; 32(3):261-8. PubMed ID: 21893978
    [Abstract] [Full Text] [Related]

  • 12. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C.
    Stroke; 2005 Oct 15; 36(10):2077-81. PubMed ID: 16179568
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.
    Zee RY, Cook NR, Cheng S, Reynolds R, Erlich HA, Lindpaintner K, Ridker PM.
    Hum Mol Genet; 2004 Feb 15; 13(4):389-96. PubMed ID: 14681304
    [Abstract] [Full Text] [Related]

  • 14. Cerebral white matter hyperintensities predict functional stroke outcome.
    Liou LM, Chen CF, Guo YC, Cheng HL, Lee HL, Hsu JS, Lin RT, Lin HF.
    Cerebrovasc Dis; 2010 Feb 15; 29(1):22-7. PubMed ID: 19893308
    [Abstract] [Full Text] [Related]

  • 15. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.
    Colaizzo D, Fofi L, Tiscia G, Guglielmi R, Cocomazzi N, Prencipe M, Margaglione M, Toni D.
    Blood Coagul Fibrinolysis; 2006 Mar 15; 17(2):93-6. PubMed ID: 16479190
    [Abstract] [Full Text] [Related]

  • 16. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T, Libman R, Tilley BC, Lewandowski C, Grotta JC, Lyden P, Levine SR, Brott T, National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
    Ann Emerg Med; 2005 Apr 15; 45(4):377-84. PubMed ID: 15795715
    [Abstract] [Full Text] [Related]

  • 17. Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population.
    Ashavaid TF, Todur SP, Kondkar AA, Nair KG, Shalia KK, Dalal JJ, Rajani R, Ponde CK.
    Platelets; 2011 Apr 15; 22(2):85-91. PubMed ID: 21034162
    [Abstract] [Full Text] [Related]

  • 18. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
    Cervera A, Tàssies D, Obach V, Amaro S, Reverter JC, Chamorro A.
    Cerebrovasc Dis; 2007 Apr 15; 24(2-3):242-6. PubMed ID: 17630485
    [Abstract] [Full Text] [Related]

  • 19. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
    Blinzler C, Breuer L, Huttner HB, Schellinger PD, Schwab S, Köhrmann M.
    Cerebrovasc Dis; 2011 Apr 15; 31(2):185-90. PubMed ID: 21160181
    [Abstract] [Full Text] [Related]

  • 20. The plasminogen activator inhibitor-1 gene polymorphism in determining the risk of pediatric ischemic stroke--case control and family-based study.
    Balcerzyk A, Żak I, Emich-Widera E, Kopyta I, Iwanicki T, Pilarska E, Pienczk-Ręcławowicz K, Kaciński M, Wendorff J, Połatyńska K.
    Neuropediatrics; 2011 Feb 15; 42(2):67-70. PubMed ID: 21647848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.